4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-22-014507
President and CEO acquired 23,724 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tesi Raymond Joseph · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-22 | Grant or award : show line 1 in the form | +23,724 | $8.43 | $199,993 | 1,514,398 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-21 | Grant or award : show line 2 in the form Option (right to buy) | +130,000 | 130,000 | D |
Loading xslF345X03/ownership.xml…